1. Home
  2. RMNI vs PEPG Comparison

RMNI vs PEPG Comparison

Compare RMNI & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rimini Street Inc. (DE)

RMNI

Rimini Street Inc. (DE)

HOLD

Current Price

$3.27

Market Cap

307.1M

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$1.63

Market Cap

353.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMNI
PEPG
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.1M
353.9M
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
RMNI
PEPG
Price
$3.27
$1.63
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$5.50
$11.17
AVG Volume (30 Days)
253.3K
2.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
197.50
25.61
EPS
0.39
N/A
Revenue
$431,496,000.00
N/A
Revenue This Year
$6.02
N/A
Revenue Next Year
$5.50
N/A
P/E Ratio
$8.56
N/A
Revenue Growth
5.33
N/A
52 Week Low
$2.87
$1.01
52 Week High
$5.38
$7.80

Technical Indicators

Market Signals
Indicator
RMNI
PEPG
Relative Strength Index (RSI) 46.99 19.38
Support Level $3.08 $1.17
Resistance Level $4.14 $5.46
Average True Range (ATR) 0.13 0.33
MACD 0.02 -0.21
Stochastic Oscillator 48.50 7.78

Price Performance

Historical Comparison
RMNI
PEPG

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: